5 Key Drugs Critical to Johnson & Johnson's Future
Johnson & Johnson (NYSE: JNJ) recently shared its third-quarter financial report card with investors, and by all measures, it deserves kudos. However, the stock market rewards investors based on future expectations, not past successes. If J&J is going to keep putting up impressive results, it's going to need to keep cashing in on its fastest-growing medicines.
Johnson & Johnson markets top consumer-goods brands like Band-Aid, and it's a big player in medical devices. But make no mistake -- this company's success or failure depends heavily on the performance of its pharmaceuticals business.
IMAGE SOURCE: GETTY IMAGES.
Source: Fool.com
Johnson & Johnson Stock
€137.20
0.320%
The stock is one of the favorites of our community with 33 Buy predictions and 1 Sell predictions.
With a target price of 195 € there is a positive potential of 42.13% for Johnson & Johnson compared to the current price of 137.2 €.
